Virinder Nohria e Earl Giller, Ganaxolone, in Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, vol. 4, n. 1, 2007-01, pp. 102–105, DOI:10.1016/j.nurt.2006.11.003. URL consultato il 13 luglio 2023.
(EN) Carter RB, Wood PL, Wieland S, Hawkinson JE, Belelli D, Lambert JJ, White HS, Wolf HH, Mirsadeghi S, Tahir SH, Bolger MB, Lan NC, Gee KW. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3α-hydroxy-3β-methyl-5α-pregnan-20-one), a selective, high-affinity, steroid modulator of the γ-aminobutyric acidA receptor. Journal of Pharmacology and Experimental Therapeutics. 1997 Mar;280(3):1284-95. PMID 9067315
(EN) Kaminski RM, Livingood MR, Rogawski MA. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia. 2004 Jul;45(7):864-7. PMID 15230714.
(EN) Reddy DS, Rogawski MA. Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res. 2010 May;89(2-3):254-60. PMID 20172694.
(EN) Reddy DS, Rogawski MA. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J Pharmacol Exp Ther. 2000 Dec;295(3):1241-8. PMID 11082461
pubmed.ncbi.nlm.nih.gov
Virinder Nohria e Earl Giller, Ganaxolone, in Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, vol. 4, n. 1, 2007-01, pp. 102–105, DOI:10.1016/j.nurt.2006.11.003. URL consultato il 13 luglio 2023.